111 Capital Buys New Shares in Alignment Healthcare, Inc. $ALHC

Key Points

• 111 Capital has acquired a new stake in Alignment Healthcare, Inc. (NASDAQ: ALHC), purchasing 23,223 shares valued at approximately $325,000 during the second quarter.
• The company's stock rose by 2.9% to $17.11, with a market capitalization of $3.39 billion and revenue up 49.0% year-over-year to $1.02 billion.
• Recent insider transactions show significant selling activity, with President Dawn Christine Maroney and CEO John E. Kao selling large quantities of shares on September 10th.

111 Capital bought a new stake in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 23,223 shares of the company's stock, valued at approximately $325,000.

Other large investors also recently modified their holdings of the company. MCF Advisors LLC lifted its stake in shares of Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock valued at $40,000 after buying an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Alignment Healthcare during the first quarter valued at about $42,000. Signaturefd LLC grew its position in shares of Alignment Healthcare by 142.6% during the second quarter. Signaturefd LLC now owns 3,768 shares of the company's stock valued at $53,000 after purchasing an additional 2,215 shares in the last quarter. Amalgamated Bank grew its position in shares of Alignment Healthcare by 21.6% during the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock valued at $65,000 after purchasing an additional 616 shares in the last quarter. Finally, Greenleaf Trust purchased a new position in shares of Alignment Healthcare during the second quarter valued at about $160,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Alignment Healthcare Stock Up 2.9%

Shares of NASDAQ ALHC opened at $17.11 on Tuesday. The firm's 50-day moving average price is $15.70 and its 200-day moving average price is $15.65. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of -61.10 and a beta of 1.18. Alignment Healthcare, Inc. has a 12-month low of $10.11 and a 12-month high of $21.06.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $960.25 million. During the same period in the prior year, the company posted ($0.13) EPS. The firm's revenue for the quarter was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Insider Buying and Selling

In related news, President Dawn Christine Maroney sold 215,662 shares of the stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the sale, the president directly owned 1,797,237 shares of the company's stock, valued at $29,492,659.17. This represents a 10.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO John E. Kao sold 355,018 shares of the stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the completion of the sale, the chief executive officer directly owned 4,533,568 shares in the company, valued at $74,395,850.88. This trade represents a 7.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,388,173 shares of company stock worth $118,068,256 over the last three months. 6.60% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

ALHC has been the subject of a number of research analyst reports. Barclays upgraded Alignment Healthcare from an "underweight" rating to an "equal weight" rating and raised their price objective for the company from $9.00 to $13.00 in a research report on Thursday, July 31st. Zacks Research upgraded Alignment Healthcare from a "hold" rating to a "strong-buy" rating in a research report on Monday, September 29th. Weiss Ratings restated a "sell (d-)" rating on shares of Alignment Healthcare in a research report on Saturday, September 27th. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Sunday, August 10th. Finally, KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 target price on the stock in a research report on Monday, August 25th. Two research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Alignment Healthcare has a consensus rating of "Moderate Buy" and an average price target of $18.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Want to see what other hedge funds are holding ALHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.